123 Mir-127–3p as a Novel Regulator of Type I Interferon Signalling Pathway in Sle

doi 10.1136/lupus-2017-000215.123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Lupus Foundation of America

Related search

miR-141-3p Is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma

OncoTargets and Therapy
OncologyPharmacology
2018English

Autoantibodies, Complement and Type I Interferon as Biomarkers for Personalized Medicine in SLE

Lupus
Rheumatology
2016English

Small RNA Sequencing Reveals miR-642a-3p as a Novel Adipocyte-Specific microRNA and miR-30 as a Key Regulator of Human Adipogenesis

Genome Biology
2011English

101 Gilz Represents a Checkpoint Limiting Cyclical Exacerbation of Inflammation in Sle by Type I Interferon

2017English

miR-222 Isoforms Are Differentially Regulated by Type-I Interferon

RNA
Molecular Biology
2017English

miR-126: A Novel Regulator in Colon Cancer

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2015English

Targeted Therapeutics in SLE: Emerging Strategies to Modulate the Interferon Pathway

Clinical and Translational Immunology
AllergyImmunologyNursing
2016English

Abrogation of Type-I Interferon Signalling Alters the Microglial Response to Aβ1–42

Scientific Reports
Multidisciplinary
2020English

Gambogic Acid Inhibits Melanoma Through Regulation of miR-199a-3p/ZEB1 Signalling

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy